1-propanol has been researched along with Dyslipidemia in 9 studies
1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This controlled, randomized clinical trial was designed to compare the efficacy and safety of fenofibrate, policosanol and a combination of these 2 in lowering low-density-lipoprotein cholesterol (LDL-C) in elderly patients with mixed dyslipidemia." | 9.27 | Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study. ( Chen, SY; Fang, NY; Jiang, H; Jiao, QP; Lu, J; Sheng, J; Wang, HY; Zheng, SB, 2018) |
| " This controlled, randomized clinical trial was designed to compare the efficacy and safety of fenofibrate, policosanol and a combination of these 2 in lowering low-density-lipoprotein cholesterol (LDL-C) in elderly patients with mixed dyslipidemia." | 5.27 | Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study. ( Chen, SY; Fang, NY; Jiang, H; Jiao, QP; Lu, J; Sheng, J; Wang, HY; Zheng, SB, 2018) |
| "Berberine (BERB) and a combination (COMB) of berberine (CAS 2086-83-1) with policosanol (CAS 557-61-9), red yeast extract (containing monacolin, CAS 557-61-9), folic acid and astaxanthin were orally administered daily for 4 weeks to 40 subjects with moderate dyslipidemias divided in two parallel groups each of 20 subjects." | 5.12 | Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. ( Cicero, AF; Rovati, LC; Setnikar, I, 2007) |
| "This study aimed to systematically investigate whether sugarcane policosanol was effective and safe on dyslipidemia." | 2.58 | Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. ( Chen, G; Dong, H; Fang, K; Gong, J; Hu, M; Huang, Z; Jiang, S; Li, J; Lu, F; Qin, X; Wang, D; Yuan, F; Zhao, Y, 2018) |
| "Dyslipidemia is a major independent and reversible risk factor for these diseases: it is estimated that a reduction of 1 mmol/l (38 mg/dl) of LDL cholesterol is associated with a risk of developing a cardiovascular complication reduced by 25%, a reduction potentially achieved by life-style improvement associated to adequate dietary supplementation with bioactive substances." | 2.53 | Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data. ( Cicero, AF; Colletti, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C | 1 |
| Ding, Y | 1 |
| Si, Q | 1 |
| Li, K | 1 |
| Xu, K | 1 |
| Gong, J | 1 |
| Qin, X | 1 |
| Yuan, F | 1 |
| Hu, M | 1 |
| Chen, G | 1 |
| Fang, K | 1 |
| Wang, D | 1 |
| Jiang, S | 1 |
| Li, J | 1 |
| Zhao, Y | 1 |
| Huang, Z | 1 |
| Dong, H | 1 |
| Lu, F | 1 |
| Marchitto, N | 1 |
| Sindona, F | 1 |
| Fabrizio, A | 1 |
| Mauti, M | 1 |
| Andreozzi, S | 1 |
| Dalmaso, S | 1 |
| Raimondi, G | 1 |
| Elseweidy, MM | 1 |
| Mohamed, HE | 1 |
| Elrashidy, RA | 1 |
| Atteia, HH | 1 |
| Elnagar, GM | 1 |
| Wang, HY | 1 |
| Jiao, QP | 1 |
| Chen, SY | 1 |
| Sheng, J | 1 |
| Jiang, H | 1 |
| Lu, J | 1 |
| Zheng, SB | 1 |
| Fang, NY | 1 |
| Landi, F | 1 |
| Martone, AM | 1 |
| Salini, S | 1 |
| Zazzara, B | 1 |
| Calvani, R | 1 |
| Marzetti, E | 1 |
| Nesci, A | 1 |
| Di Giorgio, A | 1 |
| Giupponi, B | 1 |
| Santoro, L | 1 |
| Santoliquido, A | 1 |
| Askarpour, M | 1 |
| Ghaedi, E | 1 |
| Roshanravan, N | 1 |
| Hadi, A | 1 |
| Mohammadi, H | 1 |
| Symonds, ME | 1 |
| Miraghajani, M | 1 |
| Cicero, AF | 2 |
| Colletti, A | 1 |
| Rovati, LC | 1 |
| Setnikar, I | 1 |
3 reviews available for 1-propanol and Dyslipidemia
| Article | Year |
|---|---|
Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Fatty Alco | 2018 |
Policosanol supplementation significantly improves blood pressure among adults: A systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Blood Pressure; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; Randomized Contro | 2019 |
Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
Topics: Berberine; Biological Products; Cholesterol; Clinical Trials as Topic; Dietary Supplements; Drug The | 2016 |
4 trials available for 1-propanol and Dyslipidemia
| Article | Year |
|---|---|
Multiple functions of policosanol in elderly patients with dyslipidemia.
Topics: Aged; Carotid Intima-Media Thickness; Dyslipidemias; Fatty Alcohols; Humans; Platelet Aggregation | 2020 |
Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study.
Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Dyslipidemias; Fatty Alcohols; Female; Fenofibrate; H | 2018 |
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial.
Topics: Adult; Aged; Biological Products; Chromium; Citrus; Dietary Supplements; Dyslipidemias; Endothelial | 2019 |
Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.
Topics: Anticholesteremic Agents; Berberine; Cholesterol; Dietary Supplements; Drug Combinations; Dyslipidem | 2007 |
2 other studies available for 1-propanol and Dyslipidemia
| Article | Year |
|---|---|
Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
Topics: Berberine; Biological Products; Cassia; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; | 2018 |
Inhibition of Aortic Calcification by Policosanol in Dyslipidemic Rabbits Is Enhanced by Pentoxifylline: Potential Role of PCSK9.
Topics: Alkaline Phosphatase; Animals; Anticholesteremic Agents; Aorta; Aortic Diseases; Biomarkers; Bone Mo | 2018 |